scispace - formally typeset
G

Gereon R. Fink

Researcher at Forschungszentrum Jülich

Publications -  976
Citations -  67974

Gereon R. Fink is an academic researcher from Forschungszentrum Jülich. The author has contributed to research in topics: Medicine & Functional magnetic resonance imaging. The author has an hindex of 114, co-authored 867 publications receiving 60853 citations. Previous affiliations of Gereon R. Fink include University of Geneva & University of Hamburg.

Papers
More filters
Journal ArticleDOI

Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease.

TL;DR: The results suggest that disease severity in PD patients is related to disturbances in internal action initiation, selection and simple decision processes, and add further support to the notion that dopaminergic medication differentially affects motor and cognitive performance in PD.
Journal ArticleDOI

Left hemispheric neuronal heterotopia: A PET, MRI, EEG, and neuropsychological investigation of a university student

TL;DR: It is concluded that there can be large compensations for unilateral heterotopia, especially in those regions of the left hemisphere that were expected to respond well to the activation–the temporal, parietal, and temporo-occipital cortical zones.
Journal ArticleDOI

Mirror apraxia affects the peripersonal mirror space. A combined lesion and cerebral activation study

TL;DR: It is suggested that mirror apraxia may originate from a dissociation between the representations of body schema and peripersonal space and that objects located on the body surface become integrated into the body schema.
Journal ArticleDOI

Nicotine effects on brain function during a visual oddball task: A comparison between conventional and eeg-informed fmri analysis

TL;DR: Integrated analyses of simultaneous EEG-fMRI data can be used to detect nicotine effects that would not have been revealed through conventional analysis of either measure in isolation, emphasizing the significance of applying multimodal imaging methods to pharmacoimaging.